Vanda Pharmaceuticals Inc (VNDA)
6.29
-0.06
(-0.94%)
USD |
NASDAQ |
Jun 18, 11:13
Vanda Pharmaceuticals Price to Book Value: 0.6729 for June 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 17, 2024 | 0.6793 |
| June 14, 2024 | 0.6676 |
| June 13, 2024 | 0.6954 |
| June 12, 2024 | 0.6333 |
| June 11, 2024 | 0.6408 |
| June 10, 2024 | 0.6398 |
| June 07, 2024 | 0.6547 |
| June 06, 2024 | 0.6708 |
| June 05, 2024 | 0.5403 |
| June 04, 2024 | 0.5381 |
| June 03, 2024 | 0.5478 |
| May 31, 2024 | 0.5467 |
| May 30, 2024 | 0.536 |
| May 29, 2024 | 0.5264 |
| May 28, 2024 | 0.5328 |
| May 24, 2024 | 0.5595 |
| May 23, 2024 | 0.5253 |
| May 22, 2024 | 0.5499 |
| May 21, 2024 | 0.5467 |
| May 20, 2024 | 0.5638 |
| May 17, 2024 | 0.5863 |
| May 16, 2024 | 0.597 |
| May 15, 2024 | 0.5734 |
| May 14, 2024 | 0.5488 |
| May 13, 2024 | 0.5403 |
| Date | Value |
|---|---|
| May 10, 2024 | 0.5392 |
| May 09, 2024 | 0.536 |
| May 08, 2024 | 0.5734 |
| May 07, 2024 | 0.5863 |
| May 06, 2024 | 0.5178 |
| May 03, 2024 | 0.5221 |
| May 02, 2024 | 0.5007 |
| May 01, 2024 | 0.5103 |
| April 30, 2024 | 0.5092 |
| April 29, 2024 | 0.5157 |
| April 26, 2024 | 0.4943 |
| April 25, 2024 | 0.4793 |
| April 24, 2024 | 0.4878 |
| April 23, 2024 | 0.4953 |
| April 22, 2024 | 0.5135 |
| April 19, 2024 | 0.5467 |
| April 18, 2024 | 0.5317 |
| April 17, 2024 | 0.5606 |
| April 16, 2024 | 0.4333 |
| April 15, 2024 | 0.4343 |
| April 12, 2024 | 0.4408 |
| April 11, 2024 | 0.4579 |
| April 10, 2024 | 0.4579 |
| April 09, 2024 | 0.4664 |
| April 08, 2024 | 0.4825 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3581
Minimum
Nov 09 2023
2.835
Maximum
Aug 01 2019
1.359
Average
1.321
Median
Price to Book Value Benchmarks
| ADMA Biologics Inc | 16.12 |
| INVO Bioscience Inc | -- |
| Johnson & Johnson | 5.012 |
| Ligand Pharmaceuticals Inc | 1.809 |
| Sage Therapeutics Inc | 0.9354 |
Price to Book Value Related Metrics
| PS Ratio | 2.042 |
| Price | 6.29 |
| Earnings Yield | -1.23% |
| Market Cap | 366.07M |